Friday January 8 12:00 noon CST | via Zoom Webinar
"ADHD, stimulants, and addiction treatment"
Individuals with symptoms or prior diagnoses of ADHD present frequently for substance use disorder (SUD) treatment. Despite having effective ADHD pharmacotherapy, it is often unclear whether a monitored stimulant trial would benefit or harm this group. Concerns of diversion or misuse of the prescribed controlled substance also complicate decision-making.
Current clinical practice has tended to defer ADHD medication trials until the pattern of substance use is “more stable”—often hoping that what appears to be ADHD will resolve with abstinence. This approach is problematic, since we know ADHD is prevalent in the SUD population—affecting 25% of those seeking treatment—and its symptom burden negatively affects a person’s ability to attend appointments, take medication, and prioritize long-term goals, alongside other functions required to benefit from treatment.
Here, we will use a clinical case to review the neurobiological, epidemiological, and diagnostic overlap between SUD and ADHD. A summary of accumulated evidence for pharmacologic treatment of ADHD in the SUD population will be reviewed, including new evidence for improved short- and longer-term retention in outpatient addiction treatment. Finally, we will briefly review of the risk calculus for stimulant prescribing in ADHD and SUD populations, focusing on risk of non-medical use and risk-mitigating treatment frames.
CME credit for Psychiatry Grand Rounds is only available during the live feed time and for a brief time immediately following. The code for this week's session is displayed at the opening and closing of the meeting and also in the Chair's Office Zoom Account Name during the meeting.
AMA PRA Category 1 Credit™(1.00)
CE (APA) (1.00) | Attendance (1.00)
The archived webinar can be viewed at the link below:
Jan 8 Psychiatry Grand Rounds | Addiction Case Conference
This talk is sponsored by the
Department of Psychiatry and Behavioral Sciences
This educational activity received no commercial support.
Grand Rounds Enrichment Discussion
For Psychiatry Grand Rounds Case Conferences, there will not be an accompanying GRED talk